21718 results for «»
21718 results
Sandrine Wallace
Lyon, France
Robert Mvungi
Shih-Chi Liu
Taipei
Yu-Cheng Kao
Taipei
2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James on behalf of Swedish cardiovascular registry experts
20 May 2025
The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
PCR's Got Talent Round 1 - Session 2
20 May 2025 – From EuroPCR 2025
Join the dynamic PCR's Got Talent Round 1 - Session 2 featuring cutting-edge research and innovations in interventional cardiology. Highlights include complex CTO PCI strategies, valve comparisons in TAVI for small annuli, PFO closure outcomes, long-term PCI durability, CT-guided robotic PCI, pacemaker prediction post-TAVI, and much...
EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...
The best bits of of the Course
Highlights from EAPCI-PCR Fellows Course 2024
Decompensated heart failure: indication and management of mechanical circulatory support
20 May 2025 – From EuroPCR 2025
This session reviews state-of-the-art strategies for managing life-threatening acute heart failure, focusing on indications and management of mechanical circulatory support, including cases like young myocarditis. Learn contemporary approaches for patients after mechanical circulatory support removal through interactive case discussions.
Spotlight on major Late-Breaking Trials presented at EuroPCR 2025
21 May 2025
These trials were selected because of their design, results, and potential to impact practice: Discover the key findings of the 4D-ACS and FAITAVI randomised clinical trials and a meta-analysis of PROTECTED TAVR and BHF PROTECT TAVI.
Shockwave Medical study confirms benefit of IVL-first strategy in real-world female patients with complex calcified lesions in late-breaking data presentation at EuroPCR 2025
20 May 2025
Difficult ACS case management and complication
20 May 2025 – From EuroPCR 2025
Learn expert strategies for managing challenging acute coronary syndrome (ACS) cases and complications. This session covers balloon-uncrossable CTO management in high-risk NSTEMI, iatrogenic coronary perforation during STEMI, spontaneous coronary artery dissection, and complex anterior STEMI interventions with key clinical learnings.
EuroPCR 2025: Cutting through the complexity
20 May 2025
Complexity is the fil rouge of this year’s course but what does it mean to the Course Directors? And how can EuroPCR help participants cut through the complexity?
Resilience and continuity of cardiovascular care in times of crises: the RESIL-Card project
20 May 2025 – From EuroPCR 2025
Reflect on cardiovascular care resilience during crises with insights from the RESIL-Card project initiated by the PCR community. This session shares lessons from the pandemic, presents the development of a novel resilience assessment tool, and outlines future timelines to better prepare cardiac care systems for upcoming...
EuroPCR 2025: RESIL-Card achieves a major milestone - The resilience tool is ready for pilot testing!
20 May 2025
Launched in December 2023 by our community through the ‘We CARE Alliance’ and co-funded by the EU4Health work programme, the mission of the RESIL-Card project is to ensure that essential healthcare services for people with cardiovascular (CV) diseases are maintained during crises. Specifically, the project aims to...
Nurses and allied professionals clinical cases session
20 May 2025 – From EuroPCR 2025
Highlighting the critical role of nurses and allied professionals, this session presents clinical case discussions on managing brachial dissection, rare ACS diagnosis, coronary perforation, and rotablator complications. Emphasis is placed on teamwork and training illustrated by a case of acute transcatheter aortic valve migration to optimize...
Degeneration of TAVI valves: a new target for innovations
19 May 2025 – From EuroPCR 2025
Discover the latest innovations targeting degeneration of TAVI valves, including expert presentations and cutting-edge technologies like The Splitter, an enabler for transcatheter aortic valve-in-valve implantation.
